Ticilimumab Uses, Dosage, Side Effects and more
Ticilimumab is under investigation for the treatment of Mesothelioma, Liver Cancer, Liver Neoplasms, Liver Cell Caricinoma, and HepatoCellular Carcinoma. Ticilimumab has been investigated in Part C: Malignant Mesothelioma and Part A and B: Advanced Solid Malignancies.
| Trade Name | Ticilimumab |
| Generic | Tremelimumab |
| Tremelimumab Other Names | Ticilimumab, Tremelimumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
